Thomas Puyregner

Thomas Puyregner currently serves as Senior Director and Study Start-Up Head for Europe at BeiGene since February 2023. Prior to this role, Thomas held the position of Senior Director and Global Head of Monitoring at Innovent Biologics from May 2022 to February 2023, where responsibilities included developing a global Field Operations line function for clinical activities outside of China. Thomas spent over two decades at Novartis, culminating in various leadership roles, including Director of the Project Management Office at Trial Monitoring, where a strategic transformation was executed. Key achievements at Novartis also included directing trial operations for over 100 oncology trials and establishing comprehensive operational capabilities. Earlier experience includes roles at Genset as a Genotype Analyst and academic credentials in Drug Design and Molecular Biology from institutions in France.